SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-23-049254 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: June 15, 2023 · CIK: 0001711786 · Accession: 0001213900-23-049254

AI Filing Summary & Sentiment

File numbers found in text: 333-272620

Date
June 15, 2023
Author
Not clearly detected
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

June 15, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-272620

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Standard Time, on Friday, June 16, 2023, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth Therapeutics,
Inc.

1 Rockefeller Plaza, Suite 1039

New York, New York 10020

    June 15, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

    Re:
    Hoth Therapeutics, Inc.

    Registration Statement on Form S-3

    File No. 333-272620

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Standard Time, on Friday, June 16, 2023, or as soon thereafter as possible.

Please notify Nazia Khan of
Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.

    HOTH THERAPEUTICS, INC.

    By:
    /s/ Robb Knie

    Name:
    Robb Knie

    Title:
    Chief Executive Officer